Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:42 AM
Ignite Modification Date:
2025-12-25 @ 1:42 AM
NCT ID:
NCT05771194
Eligibility Criteria:
Inclusion Criteria:
* Clinical diagnosis of dry eye
* Clinical diagnosis for MGD
Exclusion Criteria:
* eye trauma or eye surgery within the prior 6 months
* use of drugs that affect tear secretion and the stability of the tear film (including anti-glaucoma drugs, cortisol drugs, etc.) within the prior 6 months
* other diseases that affect the function of the eye surface, such as meibomian gland cysts, blepharitis, eyelid valgus, incomplete closure, chronic tear cystitis, corneal disease, glaucoma, or optic neuropathy
* intraoperative suture fixation or closure of a corneal, conjunctival, or scleral incision
* long-term postoperative intraocular hypertension that could not be controlled easily with oral drugs and required puncture and drainage through the anterior chamber
* postoperative corneal epithelial defects lasting more than 1 week or necessitating the use of contact lenses for treatment
* the need for a second operation during the study follow-up eye trauma or eye surgery within the prior 6 months
* use of drugs that affect tear secretion and the stability of the tear film (including anti-glaucoma drugs, cortisol drugs, etc.) within the prior 6 months
* other diseases that affect the function of the eye surface, such as meibomian gland cysts, blepharitis, eyelid valgus, incomplete closure, chronic tear cystitis, corneal disease, glaucoma, or optic neuropathy
* intraoperative suture fixation or closure of a corneal, conjunctival, or scleral incision
* long-term postoperative intraocular hypertension that could not be controlled easily with oral drugs and required puncture and drainage through the anterior chamber
* postoperative corneal epithelial defects lasting more than 1 week or necessitating the use of contact lenses for treatment
* the need for a second operation during the study follow-up
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
80 Years
Study:
NCT05771194
Study Brief:
Protocol Section:
NCT05771194